Dr. Alex Berlin, Chief Technology Officer
Alex has over 20 years of experience in industrial biotechnology. He led international efforts for the commercialization of plant biomass biorefinery, enzyme, and microbial fermentation technologies. Alex contributed to the advancement of Dyadic’s (USA) industrial enzymes portfolio, acquired by DuPont for $75M. Alex was Lignol’s (Canada) VP R&D leading the research and technology development of the company’s plant biomass biorefinery for the production of biofuels and lignin-based products, acquired by Fibria (Brazil). Alex was R&D Director with Novozymes (Denmark), where he contributed to the development of key enzyme and microbial fermentation products.
Alex held an Adjunct Professorship with the Biosystems Engineering Department, University of Manitoba (Canada) and served as an expert advisor to government agencies on Sustainable Energy Systems, in particular, to the National Sciences and Engineering Research Council of Canada. He holds a Ph.D. degree in Biotechnology, Chemistry & Catalysis and a M.Sc. degree in Chemistry from Moscow State University M.V. Lomonosov.